3 not yet recruiting, 2 recruiting, 1 completed. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Not yet recruiting 3, Recruiting 2, Completed 1 |
Follow CM512: new trials by email Literature Review of CM512 trials Research Report on CM512
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background Therapy CM512, Placebo - Perennial Allergic Rhinitis (PAR) | Phase 2 | Not yet recruiting | Beijing Keymed Biosciences Co., Ltd. | 200 | 2026-10-01 | 2026-10-22 |
| A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2） CM512 - Chronic Rhinosinusitis With Nasal Polyposis | Phase 2 | Not yet recruiting | Keymed Biosciences Co.Ltd | 120 | 2026-05-31 | 2026-06-30 |
| A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis. CM512 - Atopic Dermatitis (AD) | Phase 2 | Recruiting | Keymed Biosciences Co.Ltd | 246 | 2025-12-01 | 2025-11-17 |
| A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease CM512, Placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Not yet recruiting | Keymed Biosciences Co.Ltd | 204 | 2025-06-20 | 2025-05-20 |
| Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis Placebo Comparator, CM512 - Atopic Dermatitis | Phase 2 | Recruiting | Keymed Biosciences Co.Ltd | 200 | 2025-06-19 | 2025-08-17 |
| A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1） CM512, Placebo - Chronic Rhinosinusitis With Nasal Polyposis | Phase 2 | Completed | Beijing Keymed Biosciences Co., Ltd. | 120 | 2025-05-16 | 2026-08-18 |
Dermatitis, Atopic (2) · Pulmonary Disease, Chronic Obstructive (1) · Rhinitis, Allergic, Perennial (1)
Keymed Biosciences Co.Ltd (4) · Beijing Keymed Biosciences Co., Ltd. (2)
China (5)
Jianzhong Zhang (2) · Jinfu Xu (1) · Luo Zhang (1)